JPL Wealth Management, LLC
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 2010710
GREENWOOD VILLAGE, CO
Position in SUPN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,860
-$207 QoQ
Shares Held
40
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#300
of 331 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JPL Wealth Management, LLC holds $53,794 across 22 Drug Manufacturers - Specialty & Generic names. SUPN ranks #5 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
1,572 | $24,963 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
56 | $9,438 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
12 | $6,501 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
20 | $2,218 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
40 | $1,860 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
65 | $1,599 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
88 | $1,523 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
90 | $1,304 |
All Filings in SUPN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,860 | 40 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,067 | 40 | Shares | Sole | 2026-05-08 | |
| 2025-09-30 | $1,911 | 40 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||